Literature DB >> 13400136

Competitive inhibition of mammalian tyrosinase by phenylalanine and its relationship to hair pigmentation in phenylketonuria.

T B FITZPATRICK, M MIYAMOTO.   

Abstract

Entities:  

Keywords:  HAIR; MENTAL DEFICIENCY/metabolism; PIGMENTATION; TYROSINE/antagonists

Mesh：

Substances：

Year:  1957        PMID： 13400136     DOI： 10.1038/179199b0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Phenylalanine metabolism in the phenylpyruvic condition. I. Distribution, pool size, and turnover rate in human phenylketonuria.

Authors:  H D GRUMER; H KOBLET; C WOODARD
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

2.  Epinephrine metabolites and pigmentation in the central nervous system in a case of phenylpyruvic oligophrenia.

Authors:  J H FELLMAN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-02       Impact factor: 10.154

Review 3.  Human skin pigmentation, its genetics and variations.

Authors:  A K Kalla
Journal:  Humangenetik       Date:  1974-03-28

4.  Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU).

Authors:  Cary O Harding; Shelley R Winn; K Michael Gibson; Erland Arning; Teodoro Bottiglieri; Markus Grompe
Journal:  J Inherit Metab Dis       Date:  2014-02-03       Impact factor: 4.982

5.  Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria.

Authors:  C O Harding; M B Gillingham; K Hamman; H Clark; E Goebel-Daghighi; A Bird; D D Koeberl
Journal:  Gene Ther       Date:  2006-03       Impact factor: 5.250

6.  Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria.

Authors:  Christineh N Sarkissian; Alejandra Gámez; Lin Wang; Marilyse Charbonneau; Paul Fitzpatrick; Jeffrey F Lemontt; Bin Zhao; Michael Vellard; Sean M Bell; Carroll Henschell; Amy Lambert; Laurie Tsuruda; Raymond C Stevens; Charles R Scriver
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-18       Impact factor: 11.205

7.  Metabolism of phenylalanine in mice homozygous for the gene 'dilute lethal'.

Authors:  L I Woolf; A Jakubovic; F Woolf; P Bory
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

8.  A novel Pah-exon1 deleted murine model of phenylalanine hydroxylase (PAH) deficiency.

Authors:  Daelyn Y Richards; Shelley R Winn; Sandra Dudley; Lev Fedorov; Nicole Rimann; Beat Thöny; Cary O Harding
Journal:  Mol Genet Metab       Date:  2020-09-30       Impact factor: 4.797

9.  Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.

Authors:  Shelley R Winn; Tanja Scherer; Beat Thöny; Ming Ying; Aurora Martinez; Sydney Weber; Jacob Raber; Cary O Harding
Journal:  Mol Genet Metab       Date:  2017-10-19       Impact factor: 4.797

10.  Conversion of p-coumarate into caffeate by Streptomyces nigrifaciens. Purification and properties of the hydroxylating enzyme.

Authors:  A M Nambudiri; J V Bhat
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.